| 5 Medical Info Systems Stock to Buy for a Stable Portfolio | 06/24 09:20 | zacks.com |
| How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3% | 05/22 10:56 | zacks.com |
| FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER | 05/16 18:46 | prnewswire.com |
| 5 Medical Info Systems Stocks to Buy for Stable Returns | 05/10 09:31 | zacks.com |
| Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 05/06 17:03 | globenewswire.com |
| Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? | 05/06 10:56 | zacks.com |
| Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript | 05/01 21:08 | seekingalpha.com |
| Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates | 05/01 19:05 | zacks.com |
| Pulmonx Reports First Quarter 2024 Financial Results | 05/01 16:05 | globenewswire.com |
| Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 | 04/10 16:05 | globenewswire.com |